[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":2198140.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.7447,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.7457,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensation_2_Q2_USD":902979.0,"ShareBasedCompensation_1_Q2_USD":557223.0,"SeveranceCosts1_2_Q2_USD":1200000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-155400519.0,"RestructuringReserveCurrent_0_Q2_USD":677891.0,"RestructuringCosts_2_Q2_USD":1238270.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.0085,"ResearchAndDevelopmentExpense_2_Q2_USD":2947639.0,"ProceedsFromWarrantExercises_2_Q2_USD":24300.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":80468.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OtherNonoperatingIncome_2_Q2_USD":1518842.0,"OtherNonoperatingIncome_1_Q2_USD":360754.0,"OtherAssetsCurrent_0_Q2_USD":578461.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":10805.0,"ResearchAndDevelopmentExpense_1_Q2_USD":719637.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":9452.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0077,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3756046.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":47327701.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":47372581.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":10193.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":4.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":92355.0,"StockholdersEquity_0_Q2_USD":35215946.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.48,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.87,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_2_Q2_shares":83410.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1_Q2_shares":42016.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":1618784.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q2_USD":1.69,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":873594.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":578185.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.8,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4629640.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":2196969.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":0.9,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":287963.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.02,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":208208.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":1.83,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":1.65,"OperatingLeaseLiabilityCurrent_0_Q2_USD":9955.0,"OperatingIncomeLoss_2_Q2_USD":-10374223.0,"OperatingIncomeLoss_1_Q2_USD":-4771361.0,"DepositsAssetsNoncurrent_0_Q2_USD":20000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":4747.0,"CommonStockSharesOutstanding_0_Q2_shares":47477084.0,"CommonStockSharesIssued_0_Q2_shares":47477084.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"Depreciation_2_Q2_USD":28453.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-5788807.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":36816128.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":36816128.0,"AssetsCurrent_0_Q2_USD":37394589.0,"Assets_0_Q2_USD":37424041.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":557223.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":190611718.0,"AccruedVacationCurrent_0_Q2_USD":31701.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":504903.0,"AccountsPayableCurrent_0_Q2_USD":746880.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":550000.0,"DividendsCommonStockCash_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.09,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.19,"OperatingExpenses_2_Q2_USD":10374223.0,"OperatingExpenses_1_Q2_USD":4771361.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"NonoperatingIncomeExpense_2_Q2_USD":1524549.0,"NonoperatingIncomeExpense_1_Q2_USD":363426.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-8849674.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-4407935.0,"NetIncomeLoss_2_Q2_USD":-8849674.0,"NetIncomeLoss_1_Q2_USD":-4407935.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-5893575.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":104768.0,"LiabilityForUncertainTaxPositionsCurrent_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":2208095.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":37424041.0,"Liabilities_0_Q2_USD":2208095.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":5707.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":2672.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":-1025452.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":395753.0,"GeneralAndAdministrativeExpense_2_Q2_USD":6188314.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4051724.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":-93285.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":804852.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":47372581.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":47327701.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]